Literature DB >> 6123421

Histamine H1- and H2-receptor blockade does not maintain electrochemical gradients across canine gastric mucosa exposed to bile salt.

N J Gurll, J W Harmon, D G Reynolds.   

Abstract

We tested the hypothesis that histamine mediates the changes in cation permeability and potential difference characteristics of gastric mucosal barrier disruption. Canine Heidenhain pouches were exposed to 20 mM sodium taurocholate both with and without combined histamine H1- and H2-receptor blockade with diphenhydramine 2 mg/kg and metiamide 10 mumol (2.5 mg)/kg/hr. Histamine-receptor blockade did not attenuate the flux, clearance rate, or permeability of hydrogen ion due to bile salt exposure and had no effect on the fluxes of sodium, chloride, and volume. Although the potential difference was higher with combined histamine-receptor blockade, the fall in potential difference due to bile salt was not attenuated. Using a pH-stat system to measure acid loss with the incremental addition of sodium taurocholate to final concentrations of 0, 5, 10, and 20 mM, we failed to observe any difference between control and histamine-receptor blockade in hydrogen flux or permeability. Increases in gastric blood flow due to intraarterial injection of histamine were attenuated with diphenhydramine, 2 mg/kg. Further attenuation of this vasodilation was observed with the addition of a histamine H2 antagonist but not with increasing the dose of the H1 antagonist to 10 mg/kg. Thus we were unable to document that doses sufficient to antagonize histamine H1 and H2 receptors prevent the increase in sodium-hydrogen flux and decrease in potential difference observed with exposure of the canine stomach to bile salt.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123421     DOI: 10.1007/bf01296734

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Influence of the H2 antagonist, metiamide, on bile acid-induced acute gastric mucosal ulcerogenesis.

Authors:  D B McRae; W P Ritchie
Journal:  Surg Forum       Date:  1978

2.  Electrophysiological effects of burimamide and 16,16-dimethyl prostaglandin E2 on the canine gastric mucosa.

Authors:  J C Bowen; Y J Kuo; W Pawlik; D Williams; L L Shanbour; E D Jacobson
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

3.  Adrenergic mechanisms in canine gastric circulation.

Authors:  M J Zinner; J C Kerr; D G Reynolds
Journal:  Am J Physiol       Date:  1975-10

4.  Effects of salicylate and bile salt on ion transport by isolated gastric mucosa of the rabbit.

Authors:  D Fromm; J H Schwartz; R Quijano
Journal:  Am J Physiol       Date:  1976-02

5.  Histamine effects on H+ permeability by isolated gastric mucosa.

Authors:  D Fromm; M Silen; R Robertson
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

6.  Fluid produced by the gastric mucosa during damage by acetic and salicylic acids.

Authors:  H W Davenport
Journal:  Gastroenterology       Date:  1966-04       Impact factor: 22.682

7.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

8.  Destruction of the gastric mucosal barrier by detergents and urea.

Authors:  H W Davenport
Journal:  Gastroenterology       Date:  1968-02       Impact factor: 22.682

9.  Studies on the mode of action of histamine H1- and H2-receptor antagonists on gastric histamine methyltransferase.

Authors:  H Barth; I Niemeyer; W Lorenz
Journal:  Agents Actions       Date:  1973-10

10.  Identification and specific blockade of two receptors for histamine in the cardiovascular system.

Authors:  J R Powell; M J Brody
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

View more
  2 in total

1.  Histamine and gastric mucosa.

Authors:  W D Rees
Journal:  Dig Dis Sci       Date:  1984-07       Impact factor: 3.199

2.  Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview.

Authors:  E Z Dajani; C H Nissen
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.